Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · March 19, 2022

Thirty-Day Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation

JACC: Cardiovascular Interventions


Additional Info

JACC: Cardiovascular Interventions
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation: TRISCEND Study 30-Day Results
JACC Cardiovasc Interv 2022 Mar 14;15(5)471-480, S Kodali, RT Hahn, I George, CJ Davidson, A Narang, F Zahr, S Chadderdon, R Smith, PA Grayburn, WW O'Neill, DD Wang, H Herrmann, F Silvestry, S Elmariah, I Inglessis, J Passeri, DS Lim, M Salerno, M Makar, MJ Mack, MB Leon, R Makkar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading